Viewing Study NCT04017650


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-25 @ 2:32 PM
Study NCT ID: NCT04017650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2019-07-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module